Show simple item record

dc.contributor.authorMattocks, Kristin M.
dc.contributor.authorClark, Robin E.
dc.contributor.authorWeinreb, Linda
dc.date2022-08-11T08:08:22.000
dc.date.accessioned2022-08-23T15:52:46Z
dc.date.available2022-08-23T15:52:46Z
dc.date.issued2017-11-01
dc.date.submitted2017-12-22
dc.identifier.citationWomens Health Issues. 2017 Nov - Dec;27(6):646-651. doi: 10.1016/j.whi.2017.05.002. Epub 2017 Jun 19. <a href="https://doi.org/10.1016/j.whi.2017.05.002">Link to article on publisher's site</a>
dc.identifier.issn1049-3867 (Linking)
dc.identifier.doi10.1016/j.whi.2017.05.002
dc.identifier.pmid28641929
dc.identifier.urihttp://hdl.handle.net/20.500.14038/29213
dc.description.abstractPURPOSE: The purpose of this study was to explore perceptions of experiences and challenges with methadone maintenance treatment (MMT) and obstetrical care among pregnant and postpartum women enrolled in a methadone maintenance program. RESEARCH DESIGN: The study featured a grounded theory approach including two focus groups with pregnant and postpartum methadone users at a methadone maintenance clinic in Worcester, Massachusetts. Two research team members conducted and recorded focus groups, which took approximately 45 minutes to 1 hour. Grounded theory was used to guide data analysis and open coding, where transcripts were reviewed line by line to create code definitions as concepts emerged inductively from the data. RESULTS: Five emergent themes were derived from the data: 1) guilt, coupled with fear of negative outcomes for their infant, dictates women's MMT treatment decisions; 2) finding obstetricians with experience treating pregnant women using methadone can be a challenge; 3) methadone clinic physicians are instrumental in helping women find the right methadone dose during pregnancy; 4) some women had strong preferences for methadone over buprenorphine; and 5) women face substantial substance abuse treatment challenges after delivery. CONCLUSIONS: Women experience substantial challenges engaging in MMT during the perinatal period. Additional challenges arise from finding obstetrical providers who have experience with MMT and are willing to care for pregnant women. This study may provide a starting point for future interventions seeking to improve care coordination between substance abuse treatment and prenatal care programs.
dc.language.isoen_US
dc.relation<p><a href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=pubmed&cmd=Retrieve&list_uids=28641929&dopt=Abstract">Link to Article in PubMed</a></p>
dc.relation.urlhttps://doi.org/10.1016/j.whi.2017.05.002
dc.subjectMaternal and Child Health
dc.subjectObstetrics and Gynecology
dc.subjectSubstance Abuse and Addiction
dc.subjectWomen's Health
dc.titleInitiation and Engagement with Methadone Treatment among Pregnant and Postpartum Women
dc.typeJournal Article
dc.source.journaltitleWomen's health issues : official publication of the Jacobs Institute of Women's Health
dc.source.volume27
dc.source.issue6
dc.identifier.legacycoverpagehttps://escholarship.umassmed.edu/faculty_pubs/1442
dc.identifier.contextkey11292926
html.description.abstract<p>PURPOSE: The purpose of this study was to explore perceptions of experiences and challenges with methadone maintenance treatment (MMT) and obstetrical care among pregnant and postpartum women enrolled in a methadone maintenance program.</p> <p>RESEARCH DESIGN: The study featured a grounded theory approach including two focus groups with pregnant and postpartum methadone users at a methadone maintenance clinic in Worcester, Massachusetts. Two research team members conducted and recorded focus groups, which took approximately 45 minutes to 1 hour. Grounded theory was used to guide data analysis and open coding, where transcripts were reviewed line by line to create code definitions as concepts emerged inductively from the data.</p> <p>RESULTS: Five emergent themes were derived from the data: 1) guilt, coupled with fear of negative outcomes for their infant, dictates women's MMT treatment decisions; 2) finding obstetricians with experience treating pregnant women using methadone can be a challenge; 3) methadone clinic physicians are instrumental in helping women find the right methadone dose during pregnancy; 4) some women had strong preferences for methadone over buprenorphine; and 5) women face substantial substance abuse treatment challenges after delivery.</p> <p>CONCLUSIONS: Women experience substantial challenges engaging in MMT during the perinatal period. Additional challenges arise from finding obstetrical providers who have experience with MMT and are willing to care for pregnant women. This study may provide a starting point for future interventions seeking to improve care coordination between substance abuse treatment and prenatal care programs.</p>
dc.identifier.submissionpathfaculty_pubs/1442
dc.contributor.departmentDepartment of Family Medicine and Community Health
dc.contributor.departmentDepartment of Quantitative Health Sciences
dc.source.pages646-651


Files in this item

Thumbnail
Name:
Publisher version

This item appears in the following Collection(s)

Show simple item record